Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery

Completed · Phase 1/Phase 2

Conditions studied: Urinary Incontinence, Stress, Urination Disorders, Urologic Diseases, Lower Urinary Tract Symptoms, Urological Manifestations

In brief

To study the safety and potential efficacy of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) for the treatment of male stress urinary incontinence (SUI) for patients that have undergone prior prostate surgery.

Key facts

Study ID
NCT02291432
Run by
Cook MyoSite
People needed
25
Starts
2015-02-19
Expected to finish
2019-06-28
Last updated by the study team
2021-11-01

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.